骨生物工学市場- 世界の産業規模、シェア、動向、機会、予測、製品別、用途別、エンドユーザー別、地域別、競合別、2020-2030F

骨生物工学の世界市場規模は2024年に195億8,000万米ドルとなり、2030年までのCAGRは3.20%と予測期間中に目覚ましい成長を遂げると予測されています。

世界の骨生物工学市場は、骨の治癒と再生を促進するように設計された生物学的製品や材料の開発と販売を専門とする医療業界の中で急成長している分野を指します。これらの製品は、骨の成長、修復、融合を促進する整形外科手術や脊椎外科手術で一般的に使用されています。世界保健機関（WHO）によると、2030年までに60歳以上の世界人口は14億人に達し、2020年の10億人から増加すると予測されています。2050年には、この人口層は2倍の21億人になると予想されています。また、80歳以上の人口は2050年までに3倍の4億2,600万人に達すると予測されています。

市場促進要因

人口の高齢化

主な市場課題

生産コスト

主要市場動向

先端生体材料と生物製剤

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の骨生物工学市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（同種移植、骨髄吸引濃縮物、骨形成タンパク質、脱灰骨マトリックス、血漿リッチタンパク質、合成オーソバイオロジクス、粘性補充製品）
  • 用途別（骨折回復、顎顔面および歯科用途、変形性関節症および変性関節炎、軟部組織損傷、脊椎固定術）
  • エンドユーザー別（歯科医院・施設、病院、調査・学術機関、専門クリニック、その他）
  • 地域別
  • 企業別（2024）
• 製品市場マップ
  • 製品別
  • 用途別
  • エンドユーザー別
  • 地域別

第6章 北米の骨生物工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の骨生物工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋地域の骨生物工学市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米の骨生物工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの骨生物工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Stryker Corp
• DePuy Synthes Inc
• Medtronic PLC
• Osteomed LP
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• Genzyme Corp
• Arthrex Inc
• Orthofix International BV

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Osteobiologics Market was valued at USD 19.58 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 3.20% through 2030. The global osteobiologics market refers to a rapidly growing sector within the medical industry that specializes in the development and distribution of biological products and materials designed to enhance bone healing and regeneration. These products are commonly used in orthopedic and spinal surgical procedures to facilitate bone growth, repair, and fusion. According to World Health Organization, by 2030, the global population aged 60 years and over is projected to reach 1.4 billion, up from 1 billion in 2020. By 2050, this demographic is expected to double to 2.1 billion. Also, the population aged 80 years and older is anticipated to triple, reaching 426 million by 2050.

Key Market Drivers

Aging Population

The global healthcare landscape is experiencing a seismic shift, with one of the most significant factors being the rapidly aging population. As life expectancy increases and birth rates decline, the world is witnessing a demographic transformation. This aging demographic is not just impacting the social and economic fabric but also plays a pivotal role in shaping the healthcare industry. According to the fracture fixation, bone regeneration aims to restore stiffness and strength, ensuring the bone can bear physiological loads after a fracture. Fracture healing involves biological and mechanical mechanisms, occurring in cortical bone, intramedullary bone, periosteum, and soft tissues. Bone healing progresses through phases of inflammation, repair, and remodeling. Direct bone healing happens with minimal movement and direct apposition under compression.

With aging, the risk of orthopedic disorders such as osteoarthritis, osteoporosis, and degenerative joint diseases significantly increases. These conditions often result in fractures, joint degeneration, and the need for orthopedic surgeries. Osteobiologics, biological products that aid bone healing and regeneration, have become a vital component in the treatment of these disorders, providing an ideal environment for bone fusion and faster recovery.

Key Market Challenges

Cost of Production

The production of osteobiologic products can be expensive due to the need for advanced biotechnological processes and stringent quality control. The cost of materials and manufacturing can be a significant barrier to market entry for smaller companies and can influence product pricing, potentially limiting patient access to these innovative treatments.

Key Market Trends

Advanced Biomaterials and Biologics

The development of innovative biomaterials and biologics is at the forefront of the osteobiologics market. Researchers are creating new materials that mimic natural bone structures more closely and enhance the body's regenerative abilities. This includes 3D-printed implants, engineered growth factors, and synthetic

Key Market Players

• Stryker Corp
• DePuy Synthes Inc
• Medtronic PLC
• Osteomed LP
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• Genzyme Corp
• Arthrex Inc
• Orthofix International BV

Report Scope:

In this report, the Global Osteobiologics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Osteobiologics Market, By Product:

• Allografts
• Bone Marrow Aspirate Concentrate
• Bone Morphogenic Protein
• Demineralized Bone Matrices
• Plasma-Rich Protein
• Synthetic Orthobiologics
• Visco-Supplementation Products

Osteobiologics Market, By Application:

• Fracture Recovery
• Maxillofacial & Dental Applications
• Osteoarthritis & Degenerative Arthritis
• Soft-Tissue Injuries
• Spinal Fusion

Osteobiologics Market, By End User:

• Dental Clinics & Facilities
• Hospitals
• Research & Academic Institutes
• Specialty Clinics
• Others

Osteobiologics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Osteobiologics Market.

Available Customizations:

Global Osteobiologics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Osteobiologics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 5.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 5.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Product
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Osteobiologics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 6.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 6.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Osteobiologics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Osteobiologics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Osteobiologics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Osteobiologics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 7.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 7.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Osteobiologics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Osteobiologics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. France Osteobiologics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Osteobiologics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Osteobiologics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Osteobiologics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 8.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 8.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Osteobiologics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Japan Osteobiologics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. India Osteobiologics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Australia Osteobiologics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. South Korea Osteobiologics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Osteobiologics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 9.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 9.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Osteobiologics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Osteobiologics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Osteobiologics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Osteobiologics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 10.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 10.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Osteobiologics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Osteobiologics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Osteobiologics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User
  • 10.3.4. Kuwait Osteobiologics Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Product
      • 10.3.4.2.2. By Application
      • 10.3.4.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Stryker Corp
• 14.2. DePuy Synthes Inc
• 14.3. Medtronic PLC
• 14.4. Osteomed LP
• 14.5. Zimmer Biomet Holdings, Inc.
• 14.6. Smith & Nephew plc
• 14.7. Genzyme Corp
• 14.8. Arthrex Inc
• 14.9. Orthofix International BV

15. Strategic Recommendations

16. About Us & Disclaimer